Previous 10 | Next 10 |
Insider buying decreased last week with insiders purchasing $99.17 million of stock compared to $120.09 million in the week prior. Selling increased significantly with insiders selling $1.29 billion of stock last week compared to $767.49 million in the week prior. With earnings season upon us,...
An uptick in U.S. jobless claims this week is a reminder there's still a real risk of permanent job loss that could spike credit defaults and weigh down economic activity. The expiration of the $600 weekly unemployment bonus and the potential for large employers to use COVID-19 uncertain...
Last week, I reminded investors "stocks don't rise or fall in a straight line, so expecting some form of mean reversion is understandable," and this week, we saw high-flying NASDAQ stocks decline and lessor-loved baskets, such as industrial goods, climb. This rotation isn't too surprising,...
Revenue clarity and accelerating growth in the middle of recession suggests top stocks deserve premium valuations, but stocks don't rise or fall in a straight line, so expecting some form of mean reversion is understandable. That said, stocks tend to climb higher and fall further than most...
Last week, I wrote how risk of a 5% pullback was rising, and this week, uncertainty remains high enough to suggest selling rallies in sectors with demand headwinds so that cash can be used to buy better businesses where demand tailwinds are strongest. My caution stemmed from a surge in our...
For the first time since March, our favorite overbought/oversold indicator has shifted from risk reward favoring buyers to neutral. With nearly 30% of institutional quality stocks in our coverage trading 5% or more above their 200-day moving average ((DMA)), the risk of a 3% to 5% pullback in ...
Have you ever found yourself saying a stock is too expensive because it's made a big move in a short period of time? Or that a stock is too cheap to ignore because its price has fallen sharply? Anchoring bias, or the tendency to fixate on a past price when considering a new investment idea, ca...
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following two investor conferences in June: Jefferies Virtual Global Healthcare Conference Date: Wednesday, June 3, 2020 Presentation: 8:30 a.m. ET Speakers: August Troendle,...
Previously, I wrote how investors need to be more selective in picking stocks because the SPDR S&P 500 Trust ETF ( SPY ) is approaching its 200-day moving average (DMA). If I've learned anything from helping professional money managers at mutual funds and hedge funds over the past 23 yea...
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2020 financial results after the market close on Monday, July 27, 2020. The Company will host a conference call the following morning, Tuesday, July 28, 2020, at 9:00 a.m. ET...
News, Short Squeeze, Breakout and More Instantly...
Medpace Holdings Inc. Company Name:
MEDP Stock Symbol:
NASDAQ Market:
Medpace Holdings Inc. Website:
Revenue of $528.1 million in the second quarter of 2024 increased 14.6% from revenue of $460.9 million for the comparable prior-year period, representing a backlog conversion rate of 18.2%. Net new business awards were $551.0 million in the second quarter of 2024, representing a decrease ...
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...